Jupiter Topco LLC Purchases New Stake in National Health Investors, Inc. $NHI

Jupiter Topco LLC purchased a new stake in shares of National Health Investors, Inc. (NYSE:NHI) during the second quarter, HoldingsChannel reports. The institutional investor purchased 18,909 shares of the real estate investment trust’s stock, valued at approximately $1,443,000.

Several other institutional investors also recently bought and sold shares of NHI. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors in the fourth quarter worth $27,000. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC purchased a new stake in shares of National Health Investors in the fourth quarter worth about $33,000. Allworth Financial LP purchased a new stake in shares of National Health Investors in the second quarter worth about $42,000. Finally, Advisory Services Network LLC acquired a new stake in shares of National Health Investors in the third quarter valued at about $65,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Trading Down 1.4%

NHI opened at $70.90 on Friday. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.78 and a quick ratio of 6.78. The stock has a market capitalization of $3.48 billion, a PE ratio of 20.49, a P/E/G ratio of 3.84 and a beta of 0.52. The firm’s fifty day moving average price is $75.38 and its 200 day moving average price is $78.20.

National Health Investors (NYSE:NHI) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. National Health Investors’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, research analysts expect that National Health Investors, Inc. will post 4.76 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.92 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors’s dividend payout ratio is presently 108.67%.

Insider Transactions at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction on Monday, June 15th. The shares were bought at an average price of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This represents a 2.06% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the company. BMO Capital Markets dropped their target price on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a report on Monday, June 15th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Thursday, June 25th. Truist Financial dropped their price objective on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday. Wells Fargo & Company reduced their target price on shares of National Health Investors from $79.00 to $78.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Finally, Weiss Ratings downgraded shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, National Health Investors has a consensus rating of “Moderate Buy” and a consensus price target of $83.57.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.